Modulation of the immune microenvironment in high risk DCIS by intralesional injection of anti-PD-1 (pembrolizumab)M. J. Campbell, E. McCune,H. Rothschild, J. Bolen,S. VandenBerg,J. Chien,J. Wong, L. EssermanCANCER RESEARCH（2019）引用 0|浏览21暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
